Email
Password
Remember meForgot password?
    Log in with Twitter

article imageBig Pharma looking for cure for Alzheimer's Disease

By Susan Berg     Nov 2, 2010 in Lifestyle
Nearly 100 drugs are in the clinical trial phase or under federal review for use in treating Alzheimer's disease or related dementias, pharmaceutical industry analysts report.
UPI.com reports American pharmaceutical companies are focusing in on 98 new drugs for dementia, mostly Alzheimer's disease, a report released Monday by the Pharmaceutical Research and Manufacturers of America, the industry's main lobbyist, BusinesWire.com reported.
PhRMA said that the medications are either in clinical trials or are being reviewed by the U.S. Food and Drug Administration, This work shows a major commitment to Alzheimer's disease, since each new drug costs, on average, more than $1 billion to research and develop, BusinesWire.com reported.Without medical progress, healthcare costs related to Alzheimer's disease most likely will be $1.08 trillion by 2050 estimates the Alzheimer's Association.
"Alzheimer's disease is the healthcare crisis of our generation -- and our children's generation," said George Vradenburg, chairman of USAgainstAlzheimers, a patient advocacy group.
More about Alzheimers Disease, Dementia, Drugs, Clinical trial
 
Latest News
Top News